Successful treatment of remnant gastric cancer with afferent loop syndrome managed by percutaneous transhepatic cholangial drainage followed by elective gastrectomy: a case report

por Aoyama, Shu, Motoori, Masaaki, Miyazaki, Yasuhiro, Sugimoto, Tomoki, Nishizawa, Yujiro, Komatsu, Hisateru, Inoue, Akira, Kagawa, Yoshinori, Tomokuni, Akira, Iwase, Kazuhiro, Fujitani, Kazumasa
Publicado 2021

Low expression of the GOPC is a poor prognostic marker in colorectal cancer

por Ohara, Nobuyoshi, Haraguchi, Naotsugu, Koseki, Jun, Nishizawa, Yujiro, Kawai, Kenji, Takahashi, Hidekazu, Nishimura, Junichi, Hata, Taishi, Mizushima, Tsunekazu, Yamamoto, Hirofumi, Ishii, Hideshi, Doki, Yuichiro, Mori, Masaki
Publicado 2017

Randomized phase II study of SOX+B-mab versus SOX+C-mab in patients with previously untreated recurrent advanced colorectal cancer with wild-type KRAS (MCSGO-1107 study)

por Nishizawa, Yujiro, Haraguchi, Naotsugu, Kim, Hirotoshi, Ide, Yoshihito, Nakata, Ken, Okamura, Shu, Kudo, Toshihiro, Satoh, Taroh, Uemura, Mamoru, Matsuda, Chu, Mizushima, Tsunekazu, Murata, Kohei, Doki, Yuichiro, Eguchi, Hidetoshi
Publicado 2021

Oncogene c-Myc promotes epitranscriptome m(6)A reader YTHDF1 expression in colorectal cancer

por Nishizawa, Yujiro, Konno, Masamitsu, Asai, Ayumu, Koseki, Jun, Kawamoto, Koichi, Miyoshi, Norikatsu, Takahashi, Hidekazu, Nishida, Naohiro, Haraguchi, Naotsugu, Sakai, Daisuke, Kudo, Toshihiro, Hata, Taishi, Matsuda, Chu, Mizushima, Tsunekazu, Satoh, Taroh, Doki, Yuichiro, Mori, Masaki, Ishii, Hideshi
Publicado 2017